155 related articles for article (PubMed ID: 15322430)
1. Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival.
Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
Diagn Mol Pathol; 2004 Sep; 13(3):172-82. PubMed ID: 15322430
[TBL] [Abstract][Full Text] [Related]
2. Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma.
Singh RK; Dasgupta S; Bhattacharya N; Chunder N; Mondal R; Roy A; Mandal S; Roychowdhury S; Panda CK
J Cancer Res Clin Oncol; 2005 Jun; 131(6):395-406. PubMed ID: 15856299
[TBL] [Abstract][Full Text] [Related]
3. Deletion mapping of chromosome 1 in early onset and late onset breast tumors--a comparative study in eastern India.
Chunder N; Mandal S; Basu D; Roy A; Roychoudhury S; Panda CK
Pathol Res Pract; 2003; 199(5):313-21. PubMed ID: 12908521
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
Gudmundsson J; Barkardottir RB; Eiriksdottir G; Baldursson T; Arason A; Egilsson V; Ingvarsson S
Br J Cancer; 1995 Sep; 72(3):696-701. PubMed ID: 7669583
[TBL] [Abstract][Full Text] [Related]
5. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.
Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Cancer; 2008 Nov; 7():84. PubMed ID: 18990233
[TBL] [Abstract][Full Text] [Related]
6. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
Koreth J; Bakkenist CJ; McGee JO
Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
[TBL] [Abstract][Full Text] [Related]
8. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
9. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
[TBL] [Abstract][Full Text] [Related]
10. Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors.
Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
Ann Surg Oncol; 2004 Dec; 11(12):1045-55. PubMed ID: 15576832
[TBL] [Abstract][Full Text] [Related]
11. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss at chromosome 11q13 alters FGF3 gene expression in a human breast cancer progression model.
Roy D; Calaf GM
Oncol Rep; 2014 Dec; 32(6):2445-52. PubMed ID: 25333703
[TBL] [Abstract][Full Text] [Related]
13. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.
Lee AS; Seo YC; Chang A; Tohari S; Eu KW; Seow-Choen F; McGee JO
Br J Cancer; 2000 Sep; 83(6):750-5. PubMed ID: 10952779
[TBL] [Abstract][Full Text] [Related]
14. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M
Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634
[TBL] [Abstract][Full Text] [Related]
15. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R; Zhuang Z; Merino MJ; Silverberg SG
Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at 11q22-q23 in breast cancer.
Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
[TBL] [Abstract][Full Text] [Related]
20. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
Yuan B; Oechsli MN; Hendler FJ
Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
